Kanvas Biosciences

About Kanvas Biosciences

Kanvas Biosciences is dedicated to illuminating the microbiome through a full-stack technology platform for drug discovery. Their spatial mapping discovery engine reveals interactions between the host and microbiome, aiming to enable effective therapeutic interventions for better patient treatment.

Products & Services

Platform:Novel mapping technology that illuminates host-microbiome interactions in situ.

Pipeline:Live biotherapeutics designed to modulate the microbiome in health and disease.

Specialties

Microbiome drug discovery Spatial mapping technology Host-microbiome interactions Live biotherapeutics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Capital T: - FT: Venture Capital	A: 12500000 MR: - FA: $12.5 million FAN: 12500000	D: 2024-07-01 FD: 2024-07-01	6 investors
2	RT: Pre-Series A T: - FT: Pre-Series A	A: 12000000 MR: - FA: $12M FAN: 12000000	D: 2023-06-22 FD: 2023-06-22	5 investors

Venture Capital Latest

2024-07-01

$12.5M

6 investors (Pro only)

Pre-Series A 2023-06-22

$12.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Matthew P. Cheng

Co-founder and Chief Executive Officer

LinkedIn (Pro only)

H

Hao Shi

Co-founder and Chief Technical Officer

LinkedIn (Pro only)

P

Phil Burnham

Chief Scientific Officer

LinkedIn (Pro only)

L

Lee Swem

Chief Development Officer

S

Steve Kujawa

Vice President of Business Development

M

Marguerite Prior

VP Regulatory Affairs & Quality Assurance

View 9 more team members with Pro

Unlock Full Team Directory

Recent News